<![CDATA[I've never fully understood why Insilico Medicine is so popular.]]>I've never fully understood why Insilico Medicine is so popular. But talking to CEO Alex Zhavoronkov, you start to understand why the company is the way it is — and why he wants to model it after SpaceX.

What makes a "productive" AI drug development company? Are the pros and cons of licensing vs partnerships different for AI biotechs? And what does Alex really think of Flagship?

Link Preview Image
Insilico Medicine CEO on how best to use AI in drug development

In this edition of STAT's AI Prognosis: How to be a 'productive' biotech AI company, with Insilico Medicine CEO Alex Zhavoronkov, and more.

favicon

STAT (www.statnews.com)

]]>https://board.circlewithadot.net/topic/6de66278-cf55-41b2-bebc-23955e44b4d0/i-ve-never-fully-understood-why-insilico-medicine-is-so-popular.RSS for NodeTue, 07 Apr 2026 15:40:45 GMTWed, 01 Apr 2026 14:43:26 GMT60